These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25648339)

  • 1. Self-Terminating Ventricular Fibrillation in Vandetanib-Induced Torsades de Pointes.
    Loffi M; Toffetti L; Gianni C; Lombardi F
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):811-3. PubMed ID: 25648339
    [No Abstract]   [Full Text] [Related]  

  • 2. A tale of twists: loperamide-induced torsades de pointes and ventricular tachycardia storm.
    Sahu KK; El Meligy A; Mishra AK; Goyal S
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32024717
    [No Abstract]   [Full Text] [Related]  

  • 3. Ventricular Tachycardias: Characteristics and Management.
    Baldzizhar A; Manuylova E; Marchenko R; Kryvalap Y; Carey MG
    Crit Care Nurs Clin North Am; 2016 Sep; 28(3):317-29. PubMed ID: 27484660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
    Letsas KP; Filippatos GS; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Cardiology; 2006; 105(3):146-7. PubMed ID: 16449812
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug induced QT prolongation].
    Altmann D; Eggmann U; Ammann P
    Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbances of cardiac wavelength and repolarization precede Torsade de Pointes and ventricular fibrillation in Langendorff perfused rabbit hearts.
    Hondeghem LM
    Prog Biophys Mol Biol; 2016 May; 121(1):3-10. PubMed ID: 26980523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine.
    Nia AM; Fuhr U; Gassanov N; Erdmann E; Er F
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1173-5. PubMed ID: 20676621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Hotta D; Shimomura K
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 1):33-8. PubMed ID: 7681173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a model for predicting drug-induced torsades de pointes: the risky business of assessing arrhythmogenic potential.
    Yamada KA; Nerbonne JM
    Heart Rhythm; 2006 Aug; 3(8):957-8. PubMed ID: 16876746
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ventricular arrhythmias in ion channel diseases].
    Wolpert C; Vogel M; Nagel C; Herrera-Siklody C; Rüb N
    Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):169-176. PubMed ID: 28534204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmural dispersion of repolarization and drug-induced Torsade de Pointes. -A 3-D simulation study-.
    Furukawa T
    Circ J; 2011; 75(1):49-50. PubMed ID: 21173506
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation followed by torsade de pointes degenerated into ventricular fibrillation spontaneously terminated and restored sinus rhythm.
    Santoro F; Ieva R; Ferraretti A; De Gennaro L; Di Biase M; Brunetti ND
    Int J Cardiol; 2013 Jul; 166(3):e39-40. PubMed ID: 23453872
    [No Abstract]   [Full Text] [Related]  

  • 16. The Clue Is in the U Wave: Torsades de Pointes Ventricular Tachycardia in a Hypokalemic Woman on Methadone.
    Fitzpatrick JK; Goldschlager N
    Ann Emerg Med; 2018 Apr; 71(4):473-476. PubMed ID: 29566890
    [No Abstract]   [Full Text] [Related]  

  • 17. An antibiotic recipe for an arrhythmic disaster.
    McCutcheon K; Manga P
    Cardiovasc J Afr; 2015; 26(3):143-5. PubMed ID: 26592910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias.
    Hoehns JD; Stanford RH; Geraets DR; Skelly KS; Lee HC; Gaul BL
    Pharmacotherapy; 2001 Jul; 21(7):871-83. PubMed ID: 11444585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and torsade de pointes associated with indapamide.
    Letsas KP; Alexanian IP; Pappas LK; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Int J Cardiol; 2006 Oct; 112(3):373-4. PubMed ID: 16260053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG.
    Fujiki A; Yoshioka R; Sakabe M
    Heart Vessels; 2015 Mar; 30(2):235-40. PubMed ID: 24463845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.